aTyr Pharma prices $75M public offering of 9.375M shares at $8.00 per share

aTYR PHARMA INC

Gross proceeds expected ~$75M from 9,375,000 shares at $8.00/share.
Underwriters granted 30-day option to purchase up to 1,406,250 additional shares.
Offering expected to close on September 20, 2021, subject to customary conditions.
Joint book-running managers: Piper Sandler and RBC Capital Markets; Laidlaw & Co. as lead manager.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.